ClinicalTrials.gg

Novartis: Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials

The registry lists 92 Leukemia, Myelogenous, Chronic, BCR-ABL Positive studies with Novartis as lead sponsor. 10 are open to participants now and 37 have results posted.

Phase 1 16Phase 2 26Phase 3 20Phase 4 13No phase 24(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.